211 related articles for article (PubMed ID: 31843902)
1. SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis.
Greene KS; Lukey MJ; Wang X; Blank B; Druso JE; Lin MJ; Stalnecker CA; Zhang C; Negrón Abril Y; Erickson JW; Wilson KF; Lin H; Weiss RS; Cerione RA
Proc Natl Acad Sci U S A; 2019 Dec; 116(52):26625-26632. PubMed ID: 31843902
[TBL] [Abstract][Full Text] [Related]
2. SIRT5 regulation of ammonia-induced autophagy and mitophagy.
Polletta L; Vernucci E; Carnevale I; Arcangeli T; Rotili D; Palmerio S; Steegborn C; Nowak T; Schutkowski M; Pellegrini L; Sansone L; Villanova L; Runci A; Pucci B; Morgante E; Fini M; Mai A; Russo MA; Tafani M
Autophagy; 2015; 11(2):253-70. PubMed ID: 25700560
[TBL] [Abstract][Full Text] [Related]
3. SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROS.
Barreca F; Aventaggiato M; Vitiello L; Sansone L; Russo MA; Mai A; Valente S; Tafani M
Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627630
[TBL] [Abstract][Full Text] [Related]
4. Lysine succinylation and SIRT5 couple nutritional status to glutamine catabolism.
Lukey MJ; Greene KS; Cerione RA
Mol Cell Oncol; 2020; 7(3):1735284. PubMed ID: 32391426
[TBL] [Abstract][Full Text] [Related]
5. SIRT5-mediated ME2 desuccinylation promotes cancer growth by enhancing mitochondrial respiration.
Teng P; Cui K; Yao S; Fei B; Ling F; Li C; Huang Z
Cell Death Differ; 2024 Jan; 31(1):65-77. PubMed ID: 38007551
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy.
Lukey MJ; Greene KS; Erickson JW; Wilson KF; Cerione RA
Nat Commun; 2016 Apr; 7():11321. PubMed ID: 27089238
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer.
Abril YLN; Fernandez IR; Hong JY; Chiang YL; Kutateladze DA; Zhao Q; Yang M; Hu J; Sadhukhan S; Li B; He B; Remick B; Bai JJ; Mullmann J; Wang F; Maymi V; Dhawan R; Auwerx J; Southard T; Cerione RA; Lin H; Weiss RS
Oncogene; 2021 Mar; 40(9):1644-1658. PubMed ID: 33479498
[TBL] [Abstract][Full Text] [Related]
8. BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase.
Zhao S; Wang JM; Yan J; Zhang DL; Liu BQ; Jiang JY; Li C; Li S; Meng XN; Wang HQ
Cell Death Dis; 2019 Mar; 10(4):284. PubMed ID: 30910998
[TBL] [Abstract][Full Text] [Related]
9. Metabolic fingerprinting reveals extensive consequences of GLS hyperactivity.
Rumping L; Pras-Raves ML; Gerrits J; Tang YF; Willemsen MA; Houwen RHJ; van Haaften G; van Hasselt PM; Verhoeven-Duif NM; Jans JJM
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129484. PubMed ID: 31734463
[TBL] [Abstract][Full Text] [Related]
10. Circ-CREBBP promotes cell tumorigenesis and glutamine catabolism in glioma by regulating miR-375/glutaminase axis.
Zhang L; Ye L; Xu Z; Jin Y; Song D
Brain Res; 2022 Jan; 1775():147730. PubMed ID: 34813772
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of an mTORC2-PKC-NRF2 pathway that sustains the ATF4 stress response and identification of Sirt5 as a key ATF4 effector.
Li R; Wilson KF; Cerione RA
Cell Death Discov; 2022 Aug; 8(1):357. PubMed ID: 35963851
[TBL] [Abstract][Full Text] [Related]
12. HDAC4-mediated Deacetylation of Glutaminase Facilitates Glioma Stemness.
Xu G; Qu J; Zhang M
Curr Cancer Drug Targets; 2023; 23(9):742-750. PubMed ID: 36999421
[TBL] [Abstract][Full Text] [Related]
13. Set7/9 aggravates ischemic brain injury via enhancing glutamine metabolism in a blocking Sirt5 manner.
Wang J; Tan S; Zhang Y; Xu J; Li Y; Cheng Q; Ding C; Liu X; Chang J
Cell Death Differ; 2024 Apr; 31(4):511-523. PubMed ID: 38365969
[TBL] [Abstract][Full Text] [Related]
14. Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection.
Fabbrizi E; Fiorentino F; Carafa V; Altucci L; Mai A; Rotili D
Cells; 2023 Mar; 12(6):. PubMed ID: 36980194
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.
Maurer B; Rumpf T; Scharfe M; Stolfa DA; Schmitt ML; He W; Verdin E; Sippl W; Jung M
ACS Med Chem Lett; 2012 Dec; 3(12):1050-3. PubMed ID: 24900427
[TBL] [Abstract][Full Text] [Related]
16. Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.
Lukey MJ; Cluntun AA; Katt WP; Lin MJ; Druso JE; Ramachandran S; Erickson JW; Le HH; Wang ZE; Blank B; Greene KS; Cerione RA
Cell Rep; 2019 Oct; 29(1):76-88.e7. PubMed ID: 31577957
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 5-Mediated Lysine Desuccinylation Protects Mitochondrial Metabolism Following Subarachnoid Hemorrhage in Mice.
Xiao ZP; Lv T; Hou PP; Manaenko A; Liu Y; Jin Y; Gao L; Jia F; Tian Y; Li P; Zhang JH; Hu Q; Zhang X
Stroke; 2021 Dec; 52(12):4043-4053. PubMed ID: 34807744
[TBL] [Abstract][Full Text] [Related]
18. Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells.
Huang T; Liu R; Fu X; Yao D; Yang M; Liu Q; Lu WW; Wu C; Guan M
Stem Cells; 2017 Feb; 35(2):411-424. PubMed ID: 27501743
[TBL] [Abstract][Full Text] [Related]
19. Circ_0001093 promotes glutamine metabolism and cancer progression of esophageal squamous cell carcinoma by targeting miR-579-3p/glutaminase axis.
Qian CJ; Tong YY; Wang YC; Teng XS; Yao J
J Bioenerg Biomembr; 2022 Apr; 54(2):119-134. PubMed ID: 35322289
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.
Fiorentino F; Castiello C; Mai A; Rotili D
J Med Chem; 2022 Jul; 65(14):9580-9606. PubMed ID: 35802779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
